CYTX News and Press, Cytori Therapeutics Inc. From 06/13/19

SAN DIEGO, June 13, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) “the Company” will provide a live webcast to discuss its continued transformation efforts following two recent asset sales and highlight key anticipated milestones on June 19, 2019 at 4:15 PM...

SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX) today announced that it convened its annual meeting of stockholders on Tuesday, May 28, 2019 and adjourned the meeting until Tuesday, June 18, 2019, at 9:00 a.m., Pacific Time. The annual meeting was adjour...

Cytori Therapeutics (NASDAQ: CYTX ): Q1 GAAP EPS of -$0.18. More news on: Cytori Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” or the “Company”) today announced Q1 2019 financial results and provided updates on corporate activities.  Q1 2019 net loss was $3.2 million, or $0.18 per share. Op...

SAN DIEGO, April 23, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” or the “Company”) today announced a transaction to divest certain cell therapy assets to Seijirō Shirahama of Tokyo, Japan yielding $3MM in non-dilutive funding to...

Cytori Therapeutics, Inc. (CYTX) Q4 2018 Results Earnings Conference Call April 01, 2019, 08:30 AM ET Company Participants Marc Hedrick - President and Chief Executive Officer Tiago Girão - Chief Financial Officer, Outgoing Gary Titus - Chief Financial Officer, Incoming C...

Strategic focus on building a leading oncology company / Lorem Vascular cell therapy transaction yields $4MM Letter of intent for ATI-0918 filed with EMEA SAN DIEGO, April 01, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” or the “Compan...

Cytori Therapeutics (NASDAQ: CYTX ): FY GAAP EPS of -$1.74. More news on: Cytori Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

SAN DIEGO, March 29, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) will provide a live webcast of its fourth quarter and year-end financial results and business update on Monday, April 1, 2019 at 8:30 AM Eastern Time. Prior to the webcast at approximately 8:15 AM East...

SAN DIEGO, March 07, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc.  (NASDAQ: CYTX) today announced that it officially filed a formal new drug application pre-submission request to the European Medicine Agency (EMA) for Doxorubicin Hydrochloride Cytori. This submission is the pr...